Home > Balance Sheet > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹394 Cr₹286 Cr₹97 Cr₹12 Cr₹13 Cr

What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS is ₹394 Cr based on Mar2025 Consolidated results.
Year Contingent Liabilities
Mar2025₹394 Cr
Mar2024₹286 Cr
Mar2023₹97 Cr
Mar2022₹12 Cr
Mar2021₹13 Cr

How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹394 Cr
37.98
Mar2024 ₹286 Cr
194.49
Mar2023 ₹97 Cr
703.28
Mar2022 ₹12 Cr
-5.66
Mar2021 ₹13 Cr -

Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,107.4 Cr 4.8% 2.9% 23.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 1.7% 4.1% 20.5% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

4.8%

2.9%

23.5%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses